Immunotherapy trial targets bowel cancer

20 September 2019

The Royal Marsden is leading one of the world’s first trials of immunotherapy in bowel cancer that has been removed by surgery. 

Study signals new era of precision medicine for children with cancer

19 September 2019

A new study has shown the power of genetic testing to pick out the best drugs for children with cancer to extend and improve their lives – signalling a new era of precision medicine for young patients.

Targeted radiotherapy technique could cut treatment time from two months to two weeks

17 September 2019

Advanced radiotherapy technology could safely deliver curative treatment for some prostate cancer patients in just one or two weeks, according to new research published today.

Increased risk of prostate cancer in men with BRCA2 gene fault

17 September 2019

The Royal Marsden Annual General Meeting 2019

10 September 2019

Please join us for The Royal Marsden Annual General Meeting, on Wednesday 18th September 2019, 5.30pm

World-leading urologist Dr Anthony D’Amico to host lecture at The Royal Marsden

15 August 2019

Personalised ‘liquid biopsy’ could detect return of breast cancer nearly eleven months earlier than hospital scans

1 August 2019

Multicentre UK study finds new blood test could detect the return and spread of breast cancer on average 10.7 months before tumours became visible on scans or patients developed symptoms

NICE approves olaparib in Cancer Drugs Fund: Royal Marsden experts react

26 July 2019

Today NICE (National Institute for Health and Care Excellence) announced the approval of olaparib by the Cancer Drugs Fund, for women with newly diagnosed advanced BRCA-mutated ovarian cancer.

Virtual reality for patients

24 July 2019

A new study involving the use of virtual reality (VR) headsets has started at The Royal Marsden.